SCHEMBL1146840

SCHEMBL1146840

O=C(OC1C2CC3CC(C2)CC1(O)C3)C(F)(F)S(=O)(=O)[O-].c1ccc([S+](c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 7/20 0.32
KDM4E B2RXH2 1/20 0.31
HSD11B2 P80365 2/20 0.31
GABBR2 O75899 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRB2 P47870 1/20 0.30
GABBR1 Q9UBS5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525456 0.86 ALDH1A1 (0.32) HSD11B1
SCHEMBL2677369 0.79 ALDH1A1 (0.33) HSD11B1
SCHEMBL2677501 0.78 SCN9A (0.31) HSD11B1
SCHEMBL242790 0.78 P2RX7 (0.36)
SCHEMBL710675 0.78 CYP17A1 (0.34) HSD11B1HSD11B2
Adamantane SCHEMBL546396 0.77 GAA (0.38)
SCHEMBL686561 0.76 ALDH1A1 (0.31)
SCHEMBL2180802 0.76
SCHEMBL1146837 0.76 DPP8 (0.33) KDM4E
SCHEMBL546868 0.74 TSHR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2293143-B1 Novel photoresist compositions ROHM & HAAS ELECT MAT (US) 2015-09-02 EP disclosed
EP-2293143-A2 Novel resins and photoresist compositions comprising the same Rohm and Haas Electronic Materials, L.L.C. (US) 2011-03-09 EP disclosed
US-20110039206-A1 NOVEL RESINS AND PHOTORESIST COMPOSITIONS COMPRISING SAME ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) 2011-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110039206-A1 NOVEL RESINS AND PHOTORESIST COMPOSITIONS COMPRISING SAME PUF60, CAD, RARA HSD11B1 3418/4885KDM4E 522/4885HSD11B2 3595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.